Ghana vs Mozambique: Hepatitis B surface antigen (HBsAg) prevalence
Ghana
1.1%
in 2024
Mozambique
1.1%
in 2024
Ghana rank
26th
Mozambique rank
26th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Ghana
- Mozambique
How they compare
Ghana currently reports 1.1% against 1.1% in Mozambique, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Mozambique ahead.
Ghana ranks 26th and Mozambique ranks 26th of 194 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.7% | 1.5% | 0.2% | Ghana |
| 2020s | 1.2% | 1.0% | 0.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Ghana or Mozambique?
- Ghana, at 1.1% against 1.1% in Mozambique as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Ghana and Mozambique?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Mozambique?
- 10 years are reported by both, from 2015 to 2024.
- How do Ghana and Mozambique rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Ghana ranks 26th and Mozambique ranks 26th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.